040-66563334
-
Semaglutide and obesity
- March 13, 2021
- Posted by: admin
- Category: Updates
No CommentsIn patients with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight
-
Fezolinetant
- December 11, 2019
- Posted by: admin
- Category: Updates
Fezolinetant rapidly and significantly reduces moderate/severe vasomotor symptoms in menopausal women
-
Diabetes : An opportunity towards a healthy life
- September 6, 2018
- Posted by: admin
- Category: bloginfo
Importance of Lifestyle modification Diabetes is a condition with multifactorial aetiology. While your genetics can confer a certain risk it is eventually the decisions you take regarding your lifestyle which tip the scales in favour of you getting diabetes. However keep in mind that what got you into this mess can very well get you -
Methotrexate in TAO
- August 29, 2018
- Posted by: admin
- Category: Updates
Methotrexate when combined with lower dose of methylprednisolone may help improve TAO
-
Facebook live show by Dr.Anish Kolly, consultant Endocrinologist on ‘Thyroid Disorders ‘
- July 13, 2018
- Posted by: admin
- Category: bloginfo
-
Diabetes: Symptoms Causes and Treatments- Interview with Dr. Dr.Anish Kolly on NTV
- July 13, 2018
- Posted by: admin
- Category: bloginfo
-
Artificial pancreas
- July 3, 2018
- Posted by: admin
- Category: Updates
Closed-loop insulin delivery system(artificial pancreas) could improve glycemic control in hospitalised type 2 diabetes patients as compared to conventional subcutaneous insulin therapy.
-
Bone and hearing
- June 16, 2018
- Posted by: admin
- Category: Updates
Osteoporosis may be a risk factor for sudden sensorineural hearing loss among older adults
-
diabetic neuropathy measure
- June 3, 2018
- Posted by: admin
- Category: Updates
Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) is a new scale validated to assess Health-Related QOL of patients with distal sensorimotor polyneuropathy.
-
Hypophosphatemic rickets
- June 2, 2018
- Posted by: admin
- Category: Updates
Burosumab, a monoclonal antibody against FGF23, was found To Improve Rickets Severity In Children With X-Linked Hypophosphatemia.
